691877-03-9

Basic information

• Product Name: 3-Bromo-5-cyanobenzotrifluoride
• Synonyms: 3-Bromo-5-cyanobenzotrifluoride;3-Bromo-5-(trifluoromethyl)benzonitrile;3-Bromo-5-cyanobenzotrifluoride, 5-Bromo-alpha,alpha,alpha-trifluoro-m-tolunitrile;3-Bromo-5-(trifluoromethyl)benzonitrile98%
• CAS NO: 691877-03-9
• Molecular Formula: C₈H₃BrF₃N
• Molecular Weight: 250.0153296
• Mol File: 691877-03-9.mol

Chemical Properties

• Boiling Point: 216.039 °C at 760 mmHg
• Flash Point: 84.458 °C
• Appearance: /
• Density: 1.719 g/cm³
• Vapor Pressure: 0.143mmHg at 25°C
• Refractive Index: 1.517
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• Solubility: Chloroform (Slightly), Ethyl Acetate (Slightly)
• CAS DataBase Reference: 3-Bromo-5-cyanobenzotrifluoride(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Bromo-5-cyanobenzotrifluoride(691877-03-9)
• EPA Substance Registry System: 3-Bromo-5-cyanobenzotrifluoride(691877-03-9)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22-36
• Safety Statements: 26
• Hazardous Substances Data: 691877-03-9(Hazardous Substances Data)

Usage

Chemical Properties

colorless to light yellow liquid

InChI:InChI=1/C8H3BrF3N/c9-7-2-5(4-13)1-6(3-7)8(10,11)12/h1-3H

Upstream product

• 49674-28-4 3-amino-5-(trifluoromethyl)benzonitrile 
• 328-67-6 3-bromo-5-(trifluoromethyl)benzoic acid 
• 1007578-83-7 3-bromo-5-(trifluoromethyl)benzamide 

Downstream Products

• 691877-04-0 C₈H₇BrF₃N 

Relevant articles and documents

FUSED TRICYCLIC AMIDE COMPOUNDS AS MULTIPLE KINASE INHIBITORS

Provided are fused tricyclic amide compounds, pharmaceutical compositions comprising at least one such fused tricyclic compound, processes for the preparation thereof, and the use thereof in therapy. Disclosed herein are certain tricyclic amide compounds that can be useful for inhibiting multiple (specifically BRAF and/or EGFR-T790M) kinases and for treating disorders mediated thereby.

GAMMA-AMINOAMIDE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present invention is directed to compounds of the formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R11, R12, W, X, and n are defined herein, which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.